J Gynecol Oncol.  2022 Jul;33(4):e50. 10.3802/jgo.2022.33.e50.

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples

• Akahane T
• Masuda K
• Hirasawa A
• Kobayashi Y
• Ueki A
• Kawaida M
• Misu K
• Nakamura K
• Nagai S
• Chiyoda T
• Yamagami W
• Hayashi S
• Kataoka F
• Banno K
• Sugano K
• Okita H
• Kosaki K
• Nishihara H
• Aoki D

• KMID: 2537895
• DOI: http://doi.org/10.3802/jgo.2022.33.e50

Abstract

Objective
Precursor lesions may be identified in fallopian tube tissue after risk-reducing salpingo-oophorectomy (RRSO) in patients with pathogenic variants of BRCA1/2. Serous tubal intraepithelial carcinoma (STIC) is considered a precursor of high-grade serous carcinoma, whereas the significance of the p53 signature remains unclear. In this study, we investigated the relationship between the p53 signature and the risk of ovarian cancer.
Methods
We analyzed the clinicopathological findings and conducted DNA sequencing for TP53 variants of p53 signatures and STIC lesions isolated using laser capture microdissection in 13 patients with pathogenic variants of BRCA1/2 who underwent RRSO and 17 control patients with the benign gynecologic disease.
Results
TP53 pathogenic variants were detected significantly higher in RRSO group than control (p<0.001). No difference in the frequency of p53 signatures were observed between groups (53.8% vs 29.4%; p=0.17). TP53 sequencing and next-generation sequencing analysis in a patient with STIC and occult cancer revealed 2 TP53 mutations causing different p53 staining for STICs and another TP53 mutation shared between STIC and occult cancer.
Conclusion
The sequence analysis for TP53 revealed 2 types of p53 signatures, one with a risk of progression to STIC and ovarian cancer with pathological variants in TP53 and the other with a low risk of progression without pathological variants in TP53 as seen in control.

Keyword

Prophylactic Surgical Procedures; Salpingo-Oophorectomy; Genes, p53; Genes, BRCA1; Genes, BRCA2; Cystadenocarcinoma, Serous